Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Growth Factors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02562378
What this trial is testing

T-DM1 and Non-pegylated Liposomal Doxorubicin in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer

Who this might be right for
Breast Cancer
MedSIR 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT03381274
What this trial is testing

Oleclumab (MEDI9447) Epidermal Growth Factor Receptor Mutant (EGFRm) Non-small Cell Lung Cancer (NSCLC) Novel Combination Study

Who this might be right for
Carcinoma, Non-Small-Cell Lung
MedImmune LLC 43
Large-scale testing (Phase 3)Looking for participantsNCT06350097
What this trial is testing

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
AstraZeneca 582
Not applicableStudy completedNCT00991926
What this trial is testing

Growth Factor/Insulin-like Growth Factor (GH/IGF)-1 Axis in Obese Subjects in Treatment With Orlistat

Who this might be right for
Obesity
Federico II University 20
Early research (Phase 1)Study completedNCT01340040
What this trial is testing

Dose-escalation Study to Assess Safety, Tolerability and Pharmacokinetics of MEDI-573 in Japanese Subjects

Who this might be right for
CancerAdvanced Solid Malignancies
AstraZeneca 10
Large-scale testing (Phase 3)Study completedNCT01702571
What this trial is testing

Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based Treatment

Who this might be right for
Breast Cancer
Hoffmann-La Roche 2,185
Testing effectiveness (Phase 2)UnknownNCT04163419
What this trial is testing

Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis

Who this might be right for
SchwannomatosisPain
Massachusetts General Hospital 9
Testing effectiveness (Phase 2)Study completedNCT00776763
What this trial is testing

Ocular Growth Factors Profile in Proliferative Retinopathies Before and After Intravitreal Bevacizumab

Who this might be right for
Proliferative Diabetic RetinopathyAge Related Macular Degeneration
Ophthalmological Association Edelweiss 150
Not applicableNot Yet RecruitingNCT07514871
What this trial is testing

Clinical and Radiographic Evaluation of CGF and Alloplastic Grafting in Participants Undergoing the Socket Shield Technique for Immediate Anterior Maxillary Implant Placement. This Study Assesses Bone Healing and Stability When Managing the Crestal Gap in the Esthetic Zone.

Who this might be right for
Alveolar Ridge ResorptionBone Loss in the Esthetic ZoneSocket Shield Technique+4 more
Cairo University 7
Testing effectiveness (Phase 2)Study completedNCT00171587
What this trial is testing

Study of the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Effects of Vatalanib in Combination With Capecitabine in Patients With Advanced Cancer

Who this might be right for
TumorsNeoplasm Metastasis
Novartis 22
Early research (Phase 1)Study completedNCT01737008
What this trial is testing

Dacomitinib Plus Radiotherapy, With and Without Cisplatin in Patients With Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
University Health Network, Toronto 12
Testing effectiveness (Phase 2)Study completedNCT00285025
What this trial is testing

Study of the Effect of SR57667B in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Sanofi 500
Early research (Phase 1)Study completedNCT00087789
What this trial is testing

CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Sangamo Therapeutics 10
Not applicableWithdrawnNCT03519958
What this trial is testing

Epidermal Growth Factor Receptor (EGFR) T790M Mutation Testing Practices in Hong Kong

Who this might be right for
Non-small Cell Lung Cancer
AstraZeneca
Not applicableStudy completedNCT06849349
What this trial is testing

Placenta Previa and Placenta Percreta Patients During the Third Trimester

Who this might be right for
Placenta Percreta, Third TrimesterPlacenta Previa
Manisa Celal Bayar University 48
Testing effectiveness (Phase 2)Study completedNCT03797326
What this trial is testing

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)

Who this might be right for
Advanced Solid TumorsTriple Negative Breast CancerOvarian Cancer+5 more
Merck Sharp & Dohme LLC 611
Testing effectiveness (Phase 2)Study completedNCT02712008
What this trial is testing

Anti-vasculaR Endothelial Growth Factor plUs Anti-angiopoietin 2 in Fixed comBination therapY: Evaluation for the Treatment of Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Regeneron Pharmaceuticals 302
Testing effectiveness (Phase 2)Ended earlyNCT00225758
What this trial is testing

Lapatinib in Metastatic Breast Cancer Resistant to Hormone Therapy

Who this might be right for
Metastatic Breast Cancer
Gary Schwartz 27
Not applicableLooking for participantsNCT05209776
What this trial is testing

Local Inflammation in Arrhythmogenic Right Ventricular Cardiomyopathy

Who this might be right for
Arrhythmogenic Right Ventricular Dysplasia
University Hospital, Toulouse 80
Post-approval studies (Phase 4)Ended earlyNCT04707625
What this trial is testing

Vascular Endothelial Growth Factor (VEGF) Levels in Retinal Vein Occlusion (RVO) During Anti-VEGF Treatment

Who this might be right for
Retinal Vein Occlusion
Wake Forest University Health Sciences 17
Next Page